Cubicin, as successful as it is, has yet to achieve 1 billion in annual sales. Yet you claim Televancin "will be a multi-billion dollar drug" and will achieve sales "easily above a billion per year" using Cubicin to support your claim. This is pie in the sky, unsupported and fanciful thinking on your part and you know it.

Further, given the safety precautions that are attached to Televancin and the fact that THRX has priced it at a slight premium to Cubicin, what physician in their right mind is going to use Televancin over Cubicin where they are both indicated?

Now if you want to help people who read these posts, stop calling me names and start providing hard facts and evidence.